New hope for dialysis patients with stubborn high blood pressure?
NCT ID NCT06556407
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a procedure called renal denervation, which uses ultrasound to calm overactive kidney nerves, in 12 dialysis patients with hard-to-treat high blood pressure. The goal is to see if it safely lowers blood pressure over 3 to 6 months. It is a small, early-stage trial with no comparison group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ultrasound-based renal denervation
- What this could lead to
- If it works, this could offer a new way to control blood pressure in dialysis patients who don't respond to medications.
- What could go wrong
- This is a very small, early feasibility study with only 12 people and no placebo group. The procedure may not lower blood pressure enough or could have safety issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Friedrich Alexander University Erlangen Nuremberg, Department of Nephrology and Hypertension
RECRUITINGErlangen, Bavaria, 91054, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.